Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Mar;25(3):247-248.
doi: 10.5005/jp-journals-10071-23750.

Tocilizumab in COVID-19: Is the Temptation Worthwhile?

Sachin Gupta  1 , Deeksha S Tomar  1
Affiliations
Editorial

Tocilizumab in COVID-19: Is the Temptation Worthwhile?

Sachin Gupta et al. Indian J Crit Care Med. 2021 Mar.

Abstract

How to cite this article: Gupta S, Tomar DS. Tocilizumab in COVID-19: Is the Temptation Worthwhile? Indian J Crit Care Med 2021;25(3): 247-248.

Keywords: Cytokine storm; IL-6 blockade; Tocilizumab.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Similar articles

See all similar articles

References

    1. Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y et al. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis. 2020;;71((8):):1937––1942.. doi: 10.1093/cid/ciaa449. DOI: - DOI - PMC - PubMed
    1. Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M et al. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020;;2((8):):e474––e484.. doi: 10.1016/S2665-9913(20)30173-9. DOI: - DOI - PMC - PubMed
    1. Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang Lu et al. Tocilizumab for treatment of mechanically ventilated patients with COVID-19. Clin Infect Dis. 2020; doi: 10.1093/cid/ciaa954. ciaa954. DOI: - DOI - PMC - PubMed
    1. Biran N, Ip A, Ahn J, Go RC, Wang S, Mathura S et al. Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study. Lancet Rheumatol. 2020;;2((10):):e603––e612.. doi: 10.1016/S2665-9913(20)30277-0. DOI: - DOI - PMC - PubMed
    1. Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML et al. for the STOP-COVID Investigators. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med. 2021;;181((1):):41––51.. doi: 10.1001/jamainternmed.2020.6252. DOI: - DOI - PMC - PubMed

Publication types

LinkOut - more resources